应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01477 欧康维视生物-B
交易中 03-11 14:17:14
4.790
+0.040
+0.84%
最高
4.820
最低
4.370
成交量
85.65万
今开
4.580
昨收
4.750
日振幅
9.47%
总市值
39.09亿
流通市值
39.09亿
总股本
8.16亿
成交额
406.89万
换手率
0.10%
流通股本
8.16亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
歌礼制药-B盘中异动 股价大跌5.93%报6.820港元
市场透视 · 09:33
歌礼制药-B盘中异动 股价大跌5.93%报6.820港元
欧康维视生物-B盘中异动 早盘急速下跌7.79%
市场透视 · 09:30
欧康维视生物-B盘中异动 早盘急速下跌7.79%
【欧股“十一罗汉”|诺和诺德跌超8%,阿斯麦跌超4%】周一,阿斯麦控股荷兰阿姆斯特丹股价收跌4.05%,报639.00欧元。诺和诺德哥本哈根股价收跌8.07%,报549.40丹麦克朗,为2023年8月7日以来首次收盘跌穿600整数位心理关口。德国思爱普Sap跌4.78%,阿斯利康跌1.91%,LVMH集团和赛诺菲至多收跌0.69%。罗氏制药、诺华制药、雀巢则至多收涨0.87%,欧莱雅涨1.38%,葛兰素史克涨1.6%。
金融界 · 01:02
【欧股“十一罗汉”|诺和诺德跌超8%,阿斯麦跌超4%】周一,阿斯麦控股荷兰阿姆斯特丹股价收跌4.05%,报639.00欧元。诺和诺德哥本哈根股价收跌8.07%,报549.40丹麦克朗,为2023年8月7日以来首次收盘跌穿600整数位心理关口。德国思爱普Sap跌4.78%,阿斯利康跌1.91%,LVMH集团和赛诺菲至多收跌0.69%。罗氏制药、诺华制药、雀巢则至多收涨0.87%,欧莱雅涨1.38%,葛兰素史克涨1.6%。
健康元:在AI制药领域主要从CADD和AIDD两个关键方向积极探索与实践
证券之星 · 03-10 16:20
健康元:在AI制药领域主要从CADD和AIDD两个关键方向积极探索与实践
欧康维视生物-B03月10日遭主力抛售25万元
市场透视 · 03-10 16:17
欧康维视生物-B03月10日遭主力抛售25万元
【海通证券:予艾力斯“优于大市”评级,目标价86.38-98.16元】海通证券研报指出,艾力斯(688578.SH)为研发、生产和营销三位一体的创新型制药企业。目前核心管线包括伏美替尼、戈来雷赛、普拉替尼等。营收持续攀升,利润率不断向好。公司2022年实现扭亏为盈,,主要原因为伏美替尼上市后国内销售持续增长。公司发布2024年业绩快报,预计实现归母净利润14.24亿元,同比增加121.08%。该行给予公司2025年P/E 22-25倍,合理价值区间86.38-98.16元,合理市值区间388.7-441.7亿元,给予“优于大市”评级。
金融界 · 03-10 15:56
【海通证券:予艾力斯“优于大市”评级,目标价86.38-98.16元】海通证券研报指出,艾力斯(688578.SH)为研发、生产和营销三位一体的创新型制药企业。目前核心管线包括伏美替尼、戈来雷赛、普拉替尼等。营收持续攀升,利润率不断向好。公司2022年实现扭亏为盈,,主要原因为伏美替尼上市后国内销售持续增长。公司发布2024年业绩快报,预计实现归母净利润14.24亿元,同比增加121.08%。该行给予公司2025年P/E 22-25倍,合理价值区间86.38-98.16元,合理市值区间388.7-441.7亿元,给予“优于大市”评级。
港股异动 | 昭衍新药(06127)尾盘涨超7% AI制药潜力释放 有望赋能公司药物非临床研究
智通财经 · 03-10 15:10
港股异动 | 昭衍新药(06127)尾盘涨超7% AI制药潜力释放 有望赋能公司药物非临床研究
印度最大制药商同意以3.55亿美元收购Checkpoint Therapeutics(CKPT.US)
智通财经 · 03-10 14:36
印度最大制药商同意以3.55亿美元收购Checkpoint Therapeutics(CKPT.US)
【AH互动】A股三大指数小幅高开 沪指微涨0.02% DRG/DIP、AI制药等概念板块涨幅居前
金吾财讯 · 03-10 09:29
【AH互动】A股三大指数小幅高开 沪指微涨0.02% DRG/DIP、AI制药等概念板块涨幅居前
跨国制药巨头裁员近7000人!
医药之梯 · 03-09 21:30
跨国制药巨头裁员近7000人!
【华纳药厂:拟投资不超过5亿元建设年产3000吨高端原料药及中间体绿色智造基地(二期)建设项目】华纳药厂公告,公司拟以全资孙公司湖南华纳大药厂致根制药有限公司为实施主体,建设“年产3000吨高端原料药及中间体绿色智造基地(二期)建设项目”。该项目预计总投资额不超过5亿元,资金来源主要为自有、自筹资金。项目建设地点位于湖南省长沙市望城区,预计建设周期为1-3年。项目将新增建设左卡尼汀、硫酸氢氯吡格雷等产品生产线,旨在扩大公司原料药产品的生产规模,提高绿色、智能化生产水平,充分发挥原料制剂一体化优势,提高产业配套及盈利能力。
金融界 · 03-09 17:49
【华纳药厂:拟投资不超过5亿元建设年产3000吨高端原料药及中间体绿色智造基地(二期)建设项目】华纳药厂公告,公司拟以全资孙公司湖南华纳大药厂致根制药有限公司为实施主体,建设“年产3000吨高端原料药及中间体绿色智造基地(二期)建设项目”。该项目预计总投资额不超过5亿元,资金来源主要为自有、自筹资金。项目建设地点位于湖南省长沙市望城区,预计建设周期为1-3年。项目将新增建设左卡尼汀、硫酸氢氯吡格雷等产品生产线,旨在扩大公司原料药产品的生产规模,提高绿色、智能化生产水平,充分发挥原料制剂一体化优势,提高产业配套及盈利能力。
每周股票复盘:健康元(600380)药业股份回购进展与AI制药布局
证券之星 · 03-08
每周股票复盘:健康元(600380)药业股份回购进展与AI制药布局
每周股票复盘:羚锐制药(600285)完成银谷制药90%股权收购及大股东股份质押变动
证券之星 · 03-08
每周股票复盘:羚锐制药(600285)完成银谷制药90%股权收购及大股东股份质押变动
美国商务部长:美国希望通过关税壁垒的支持,将制药和半导体制造业带回本土。
美港电讯 · 03-07
美国商务部长:美国希望通过关税壁垒的支持,将制药和半导体制造业带回本土。
歌礼制药-B03月07日遭主力抛售409万元
市场透视 · 03-07
歌礼制药-B03月07日遭主力抛售409万元
欧康维视生物-B03月07日主力净流出58万元 散户资金买入
市场透视 · 03-07
欧康维视生物-B03月07日主力净流出58万元 散户资金买入
【亚太主要股指收盘全线下跌,日经225指数跌2.17%】3月7日,亚太主要股指收盘全线下跌,日经225指数跌2.17%报36887.17点,本周累计跌0.72%,权重股方面,任天堂跌9.22%,中外制药跌5.29%,索尼跌4.24%,日立跌4.22%,迅销跌3.64%。韩国综合指数跌0.49%报2563.48点,本周累计涨1.21%,权重股方面,梅里茨金融跌6.45%,三星火灾海上保险跌3.5%。澳洲标普200指数跌1.81%报7948.2点,本周累计跌2.74%。新西兰标普50指数跌0.23%报12399.78点,本周累计跌1.6%。
金融界 · 03-07
【亚太主要股指收盘全线下跌,日经225指数跌2.17%】3月7日,亚太主要股指收盘全线下跌,日经225指数跌2.17%报36887.17点,本周累计跌0.72%,权重股方面,任天堂跌9.22%,中外制药跌5.29%,索尼跌4.24%,日立跌4.22%,迅销跌3.64%。韩国综合指数跌0.49%报2563.48点,本周累计涨1.21%,权重股方面,梅里茨金融跌6.45%,三星火灾海上保险跌3.5%。澳洲标普200指数跌1.81%报7948.2点,本周累计跌2.74%。新西兰标普50指数跌0.23%报12399.78点,本周累计跌1.6%。
AI制药有望重塑医药未来图景 港股生物技术板块强势上涨
新浪港股 · 03-07
AI制药有望重塑医药未来图景 港股生物技术板块强势上涨
吉林天衡英睿制药有限公司申请III类会议
金融界 · 03-07
吉林天衡英睿制药有限公司申请III类会议
美国商务部长:特朗普或推迟对USMCA范围内的商品和服务加征关税
美港电讯 · 03-06
美国商务部长:特朗普或推迟对USMCA范围内的商品和服务加征关税
加载更多
公司概况
公司名称:
欧康维视生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
欧康维视生物是一家主要从事眼科疗法发现、开发及商业化业务的中国控股公司。其主要产品包括OT-401(YUTIQ)、OT-1001(ZERVIATE)、OT-502(DEXYCU)、OT-301(NCX 470)、OT-101和OT-202等。该公司在中国境内开展业务。
发行价格:
--
{"stockData":{"symbol":"01477","market":"HK","secType":"STK","nameCN":"欧康维视生物-B","latestPrice":4.79,"timestamp":1741673535688,"preClose":4.75,"halted":0,"volume":856500,"delay":0,"floatShares":816000000,"shares":816000000,"eps":-0.6269124137076538,"marketStatus":"交易中","change":0.04,"latestTime":"03-11 14:17:14","open":4.58,"high":4.82,"low":4.37,"amount":4068920,"amplitude":0.094737,"askPrice":4.81,"askSize":7000,"bidPrice":4.79,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":-0.5274673134598503,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741680600000},"marketStatusCode":2,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":4.75,"openAndCloseTimeList":[[1741656600000,1741665600000],[1741669200000,1741680000000]],"volumeRatio":0.586213,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01477","defaultTab":"news","newsList":[{"id":"2518731994","title":"歌礼制药-B盘中异动 股价大跌5.93%报6.820港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518731994?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:33","pubTimestamp":1741656819,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时33分,歌礼制药-B股票出现波动,股价快速下挫5.93%。截至发稿,该股报6.820港元/股,成交量9.8万股,换手率0.01%,振幅5.79%。资金方面,该股资金流入14.575万港元,流出41.807万港元。歌礼制药-B股票所在的生物技术行业中,整体跌幅为0.07%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110933399640ca46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110933399640ca46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01477","BK1515","BK1161","01672","BK1191"],"gpt_icon":0},{"id":"2518630730","title":"欧康维视生物-B盘中异动 早盘急速下跌7.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518630730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518630730?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:30","pubTimestamp":1741656610,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时30分,欧康维视生物-B股票出现波动,股价快速下挫7.79%。欧康维视生物-B股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,荃信生物-B、东曜药业-B、百济神州涨幅较大,振幅较大的相关个股有欧康维视生物-B、来凯医药-B、科济药业-B,振幅分别为4.42%、4.25%、3.80%。欧康维视生物-B公司简介:欧康维视生物是一家主要从事眼科疗法发现、开发及商业化业务的中国控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031109301098a32deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031109301098a32deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2518208405","title":"【欧股“十一罗汉”|诺和诺德跌超8%,阿斯麦跌超4%】周一,阿斯麦控股荷兰阿姆斯特丹股价收跌4.05%,报639.00欧元。诺和诺德哥本哈根股价收跌8.07%,报549.40丹麦克朗,为2023年8月7日以来首次收盘跌穿600整数位心理关口。德国思爱普Sap跌4.78%,阿斯利康跌1.91%,LVMH集团和赛诺菲至多收跌0.69%。罗氏制药、诺华制药、雀巢则至多收涨0.87%,欧莱雅涨1.38%,葛兰素史克涨1.6%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208405","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208405?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:02","pubTimestamp":1741626170,"startTime":"0","endTime":"0","summary":"周一,阿斯麦控股荷兰阿姆斯特丹股价收跌4.05%,报639.00欧元。诺和诺德哥本哈根股价收跌8.07%,报549.40丹麦克朗,为2023年8月7日以来首次收盘跌穿600整数位心理关口。德国思爱普Sap跌4.78%,阿斯利康跌1.91%,LVMH集团和赛诺菲至多收跌0.69%。罗氏制药、诺华制药、雀巢则至多收涨0.87%,欧莱雅涨1.38%,葛兰素史克涨1.6%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11010248641321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","IE00BD6J9T35.USD","LU0823434740.USD","LU0109394709.USD","BK4599","NVO","LU0154236417.USD","LU0320765992.SGD","LU2456880835.USD","BK4212","AZN","LU1734074674.USD","LU0345774631.USD","IE0002141913.USD","ASML","LU0097036916.USD","BK4568","LU2236285917.USD","IE00BJJMRZ35.SGD","NVS","BK4543","LU1093756168.USD","LU0211331839.USD","GSK","BK4532","LRLCY","IE00BKVL7J92.USD","IE00BFTCPJ56.SGD","LU0823434583.USD","NSRGY","GSK.UK","LU2063271972.USD","BK4588","LU1829250122.USD","IE0009355771.USD","BK4585","BK4578","BK4147","IE00B4R5TH58.HKD","BK4007","01477","LU2417539215.USD","03165","LU1093756325.SGD","LU0345774391.USD","LU0889565916.HKD","LU2462157665.USD","BK4183","IE0004445239.USD","BK1574"],"gpt_icon":0},{"id":"2518218455","title":"健康元:在AI制药领域主要从CADD和AIDD两个关键方向积极探索与实践","url":"https://stock-news.laohu8.com/highlight/detail?id=2518218455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518218455?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:20","pubTimestamp":1741594812,"startTime":"0","endTime":"0","summary":"在AI制药领域,公司主要从CADD和AIDD两个关键方向积极探索与实践。在CADD方面,公司重点聚焦COPD领域,针对相关信号通路靶点展开虚拟对接筛选工作。通过CADD技术,我们能够基于小分子数据库对活性化合物进行筛选;在AIDD方面,公司在分子发现、药学研究、临床研究等多个关键环节深入应用。公司始终致力于在AI制药领域不断探索创新,为药物研发赋能,提升公司在医药领域的核心竞争力,持续为股东创造价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000020778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK1574","BK0188","BK0046","600380","01477","BK0028","BK0114","BK1191"],"gpt_icon":0},{"id":"2518108102","title":"欧康维视生物-B03月10日遭主力抛售25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518108102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518108102?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:17","pubTimestamp":1741594634,"startTime":"0","endTime":"0","summary":"03月10日, 欧康维视生物-B股价跌1.04%,报收4.75元,成交金额631万元,换手率0.16%,振幅6.04%,量比0.56。欧康维视生物-B今日主力资金净流出25万元,上一交易日主力净流出58万元。该股近5个交易日上涨6.26%,主力资金累计净流入183万元;近20日主力资金累计净流入125万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170757abf297dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170757abf297dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2518874294","title":"【海通证券:予艾力斯“优于大市”评级,目标价86.38-98.16元】海通证券研报指出,艾力斯(688578.SH)为研发、生产和营销三位一体的创新型制药企业。目前核心管线包括伏美替尼、戈来雷赛、普拉替尼等。营收持续攀升,利润率不断向好。公司2022年实现扭亏为盈,,主要原因为伏美替尼上市后国内销售持续增长。公司发布2024年业绩快报,预计实现归母净利润14.24亿元,同比增加121.08%。该行给予公司2025年P/E 22-25倍,合理价值区间86.38-98.16元,合理市值区间388.7-441.7亿元,给予“优于大市”评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518874294","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518874294?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:56","pubTimestamp":1741593391,"startTime":"0","endTime":"0","summary":"海通证券研报指出,艾力斯(688578.SH)为研发、生产和营销三位一体的创新型制药企业。目前核心管线包括伏美替尼、戈来雷赛、普拉替尼等。营收持续攀升,利润率不断向好。公司2022年实现扭亏为盈,,主要原因为伏美替尼上市后国内销售持续增长。公司发布2024年业绩快报,预计实现归母净利润14.24亿元,同比增加121.08%。该行给予公司2025年P/E 22-25倍,合理价值区间86.38-98.16元,合理市值区间388.7-441.7亿元,给予“优于大市”评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/10155648624084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01477","688578"],"gpt_icon":0},{"id":"2518295302","title":"港股异动 | 昭衍新药(06127)尾盘涨超7% AI制药潜力释放 有望赋能公司药物非临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2518295302","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518295302?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:10","pubTimestamp":1741590618,"startTime":"0","endTime":"0","summary":"海通证券指出,在药物非临床研究领域,昭衍新药引进了数字病理辅助分析系统,该系统实现了包括实验动物种属多脏器类别的AI辅助诊断、数字切片智能质控、AI模型自主训练等场景的应用。AI辅助诊断的应用使病理诊断更快、更精准。采用AI分析数据后,人效比在部分环节实现进一步提高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0216","BK1141","BK1576","603127","06127","01477","BK1574"],"gpt_icon":0},{"id":"2518260146","title":"印度最大制药商同意以3.55亿美元收购Checkpoint Therapeutics(CKPT.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518260146","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518260146?lang=zh_cn&edition=full","pubTime":"2025-03-10 14:36","pubTimestamp":1741588567,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,印度最大的制药商印度太阳制药同意以3.55亿美元的预付款收购美国免疫治疗和肿瘤学公司Checkpoint Therapeutics,以加强其专业治疗组合。Checkpoint在周一提交给交易所的一份文件中表示,印度太阳制药将以每股4.10美元的先期价格收购该公司已发行股票。Checkpoint的疗法UNLOXCYT已获得美国食品和药物管理局批准,用于治疗成人转移性皮肤鳞状细胞癌,这是美国第二常见的皮肤癌类型。印度太阳制药表示,这笔每股4.10美元的预付款比Checkpoint上周五的收盘价高出66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4139","CKPT","01477","BK1574","LENZ"],"gpt_icon":0},{"id":"2518210253","title":"【AH互动】A股三大指数小幅高开 沪指微涨0.02% DRG/DIP、AI制药等概念板块涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2518210253","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518210253?lang=zh_cn&edition=full","pubTime":"2025-03-10 09:29","pubTimestamp":1741570196,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股三大指数小幅高开,沪指微涨0.02%,深成指涨0.18%,创业板指涨0.26%。板块方面,DRG/DIP、AI制药、SPD等概念板块涨幅居前;ERP、国资云、腾讯云等概念板块受压居前。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200915/ZTMxNjQ3ZDUxMTYwMDE1MDQzMDE2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/ZTMxNjQ3ZDUxMTYwMDE1MDQzMDE2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954658","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","01477","DIP","399300","BK1191","BK1574"],"gpt_icon":0},{"id":"2518285359","title":"跨国制药巨头裁员近7000人!","url":"https://stock-news.laohu8.com/highlight/detail?id=2518285359","media":"医药之梯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518285359?lang=zh_cn&edition=full","pubTime":"2025-03-09 21:30","pubTimestamp":1741527000,"startTime":"0","endTime":"0","summary":"3月5日,拜耳发布财报,财报显示,2024年营收466.06亿欧元,同比下滑2.2%,中国区收入36亿欧元,与2023年同比下滑0.7%。2024年,拜耳的制药业务收入181.31 亿欧元,同比增长 0.3%,制药业务的研发投入 33.66 亿欧元,同比增长 1.2%。财报中指出目前公司共有92815名员工,与2023年相比减少 6908 人。2024年,拜耳加速推进组织架构精简,裁员重点直指管理层。第四季度初制药商业化部门裁员基本完成,全球员工总数降至98189人,同比减少3.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-09/doc-inepakse1482714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01477","BK1191","BK1574"],"gpt_icon":0},{"id":"2518401154","title":"【华纳药厂:拟投资不超过5亿元建设年产3000吨高端原料药及中间体绿色智造基地(二期)建设项目】华纳药厂公告,公司拟以全资孙公司湖南华纳大药厂致根制药有限公司为实施主体,建设“年产3000吨高端原料药及中间体绿色智造基地(二期)建设项目”。该项目预计总投资额不超过5亿元,资金来源主要为自有、自筹资金。项目建设地点位于湖南省长沙市望城区,预计建设周期为1-3年。项目将新增建设左卡尼汀、硫酸氢氯吡格雷等产品生产线,旨在扩大公司原料药产品的生产规模,提高绿色、智能化生产水平,充分发挥原料制剂一体化优势,提高产业配套及盈利能力。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518401154","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518401154?lang=zh_cn&edition=full","pubTime":"2025-03-09 17:49","pubTimestamp":1741513769,"startTime":"0","endTime":"0","summary":"华纳药厂公告,公司拟以全资孙公司湖南华纳大药厂致根制药有限公司为实施主体,建设“年产3000吨高端原料药及中间体绿色智造基地(二期)建设项目”。该项目预计总投资额不超过5亿元,资金来源主要为自有、自筹资金。项目建设地点位于湖南省长沙市望城区,预计建设周期为1-3年。项目将新增建设左卡尼汀、硫酸氢氯吡格雷等产品生产线,旨在扩大公司原料药产品的生产规模,提高绿色、智能化生产水平,充分发挥原料制剂一体化优势,提高产业配套及盈利能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/09174948614935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","688799","01477","BK1191","BK0239"],"gpt_icon":0},{"id":"2517460538","title":"每周股票复盘:健康元(600380)药业股份回购进展与AI制药布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2517460538","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517460538?lang=zh_cn&edition=full","pubTime":"2025-03-08 07:46","pubTimestamp":1741391169,"startTime":"0","endTime":"0","summary":"截至2025年3月7日收盘,健康元报收于11.26元,较上周的11.24元上涨0.18%。本周,健康元3月4日盘中最高价报11.43元。本周关注点公司公告汇总:健康元药业已累计回购股份43,843,462股,支付总金额为48,978.52万元。公司公告汇总健康元药业集团股份有限公司发布股份回购进展公告。2025年2月,公司回购股份992,800股,占总股本的0.05%,支付金额为1,085.83万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030800059619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01477","BK0114","BK0028","BK0188","600380","BK0046","BK0239","BK1191","BK1574","BK0077"],"gpt_icon":0},{"id":"2517467417","title":"每周股票复盘:羚锐制药(600285)完成银谷制药90%股权收购及大股东股份质押变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2517467417","media":"证券之星","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517467417?lang=zh_cn&edition=full","pubTime":"2025-03-08 07:33","pubTimestamp":1741390388,"startTime":"0","endTime":"0","summary":"截至2025年3月7日收盘,羚锐制药报收于20.29元,较上周的20.37元下跌0.39%。羚锐制药关于大股东部分股份解除质押及再质押的公告。羚锐集团持有公司股票121,817,898股,占公司总股本21.48%。羚锐集团本次解除质押股份4,800,000股,占其所持股份比例3.94%,占公司总股本比例0.85%,解除质押时间为2025年3月3日。截至本公告披露日,羚锐集团及其一致行动人持有本公司股份累计质押数量为32,130,000股,占其合计持股数量比例25.14%,占公司总股本5.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030800059585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600285","BK1574","01477","BK0077","BK1191","BK0070","BK0239"],"gpt_icon":0},{"id":"2517433863","title":"美国商务部长:美国希望通过关税壁垒的支持,将制药和半导体制造业带回本土。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433863","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517433863?lang=zh_cn&edition=full","pubTime":"2025-03-07 21:41","pubTimestamp":1741354880,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","159582","01477","BK1191"],"gpt_icon":0},{"id":"2517110937","title":"歌礼制药-B03月07日遭主力抛售409万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517110937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517110937?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335427,"startTime":"0","endTime":"0","summary":"03月07日, 歌礼制药-B股价跌2.82%,报收6.90元,成交金额3108万元,换手率0.46%,振幅4.51%,量比0.36。歌礼制药-B今日主力资金净流出409万元,上一交易日主力净流出109万元。该股近5个交易日上涨4.55%,主力资金累计净流入230万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3071万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170955a263e10f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170955a263e10f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","BK1515","01477","01672","BK1574"],"gpt_icon":0},{"id":"2517105822","title":"欧康维视生物-B03月07日主力净流出58万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517105822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517105822?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:15","pubTimestamp":1741335354,"startTime":"0","endTime":"0","summary":"03月07日, 欧康维视生物-B股价跌2.24%,报收4.80元,成交金额1237万元,换手率0.31%,振幅6.31%,量比0.72。欧康维视生物-B今日主力资金净流出58万元,上一交易日主力净流入129万元。该股近5个交易日上涨5.96%,主力资金累计净流入203万元;近20日主力资金累计净流入150万元,其中净流入天数为8日。该股主力净额占比0.01%,港股市场排名2378/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170204a263dca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170204a263dca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2517974178","title":"【亚太主要股指收盘全线下跌,日经225指数跌2.17%】3月7日,亚太主要股指收盘全线下跌,日经225指数跌2.17%报36887.17点,本周累计跌0.72%,权重股方面,任天堂跌9.22%,中外制药跌5.29%,索尼跌4.24%,日立跌4.22%,迅销跌3.64%。韩国综合指数跌0.49%报2563.48点,本周累计涨1.21%,权重股方面,梅里茨金融跌6.45%,三星火灾海上保险跌3.5%。澳洲标普200指数跌1.81%报7948.2点,本周累计跌2.74%。新西兰标普50指数跌0.23%报12399.78点,本周累计跌1.6%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517974178","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517974178?lang=zh_cn&edition=full","pubTime":"2025-03-07 14:50","pubTimestamp":1741330248,"startTime":"0","endTime":"0","summary":"3月7日,亚太主要股指收盘全线下跌,日经225指数跌2.17%报36887.17点,本周累计跌0.72%,权重股方面,任天堂跌9.22%,中外制药跌5.29%,索尼跌4.24%,日立跌4.22%,迅销跌3.64%。韩国综合指数跌0.49%报2563.48点,本周累计涨1.21%,权重股方面,梅里茨金融跌6.45%,三星火灾海上保险跌3.5%。澳洲标普200指数跌1.81%报7948.2点,本周累计跌2.74%。新西兰标普50指数跌0.23%报12399.78点,本周累计跌1.6%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07145048587172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1502","06288","BK4577","BK4571","BK4085","BK4604","BK4585","BK4206","BK4588","BK1114","HTHIY","NTDOY","000008.SH","BK4554","159940","BK1574","BK4078","01477","BK1191","LU0154236417.USD","SONY"],"gpt_icon":0},{"id":"2517673123","title":"AI制药有望重塑医药未来图景 港股生物技术板块强势上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2517673123","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517673123?lang=zh_cn&edition=full","pubTime":"2025-03-07 11:50","pubTimestamp":1741319400,"startTime":"0","endTime":"0","summary":" 3月7日消息,港股生物技术板块早盘强势,云顶新耀涨超16%,百奥赛图涨超9%,腾盛博药、金斯瑞生物科技涨超7%。 消息面上,全国人大代表、步长制药副董事长赵菁提出AI赋能中医药传承创新。AI有望重塑药物发现的模式,并且为制药行业带来潜移默化且持续地降本增效,驱动AI制药管线和市场的快速增长,看好AI制药行业长期的发展潜力及前景。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-03-07/doc-inenuzhq9991819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","HSCEI","01477","BK1191","159938","YANG","09939","HSTECH","BK1574","BK1515"],"gpt_icon":0},{"id":"2517119050","title":"吉林天衡英睿制药有限公司申请III类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2517119050","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517119050?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:18","pubTimestamp":1741299486,"startTime":"0","endTime":"0","summary":"金融界3月7日消息,据CDE官网沟通交流公示,于3月7日收到吉林天衡英睿制药有限公司申请的“III类会议”,当前状态“处理中”。吉林天衡英睿制药有限公司,成立于2020年,位于通化市,是一家以从事医药制造业为主的企业。通过天眼查大数据分析,吉林天衡英睿制药有限公司参与招投标项目8次,专利信息1条,此外企业还拥有行政许可7个。主要股东信息显示,吉林天衡英睿制药有限公司由吉林天衡药业有限公司持股100%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/07061848578769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","III","BK4134","01477","BK1191"],"gpt_icon":0},{"id":"2517164721","title":"美国商务部长:特朗普或推迟对USMCA范围内的商品和服务加征关税","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164721","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164721?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:58","pubTimestamp":1741276720,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"204eb4b4f8b4b461e6c8180fec79618a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","BK1191","01477","159582"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocumension.com","stockEarnings":[{"period":"1week","weight":0.0626},{"period":"1month","weight":0.1446},{"period":"3month","weight":-0.0519},{"period":"6month","weight":0.082},{"period":"1year","weight":-0.0759},{"period":"ytd","weight":0.0556}],"compareEarnings":[{"period":"1week","weight":0.0338},{"period":"1month","weight":0.1254},{"period":"3month","weight":0.1709},{"period":"6month","weight":0.3901},{"period":"1year","weight":0.4543},{"period":"ytd","weight":0.1856}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"欧康维视生物是一家主要从事眼科疗法发现、开发及商业化业务的中国控股公司。其主要产品包括OT-401(YUTIQ)、OT-1001(ZERVIATE)、OT-502(DEXYCU)、OT-301(NCX 470)、OT-101和OT-202等。该公司在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.116968},{"month":2,"riseRate":0.4,"avgChangeRate":-0.049128},{"month":3,"riseRate":0.6,"avgChangeRate":0.044424},{"month":4,"riseRate":0.25,"avgChangeRate":0.004659},{"month":5,"riseRate":0.5,"avgChangeRate":0.068025},{"month":6,"riseRate":0.75,"avgChangeRate":0.066459},{"month":7,"riseRate":0.5,"avgChangeRate":-0.028018},{"month":8,"riseRate":0.4,"avgChangeRate":-0.050881},{"month":9,"riseRate":0.2,"avgChangeRate":-0.087999},{"month":10,"riseRate":0.2,"avgChangeRate":-0.144034},{"month":11,"riseRate":0.4,"avgChangeRate":0.008996},{"month":12,"riseRate":0.6,"avgChangeRate":0.089218}],"exchange":"SEHK","name":"欧康维视生物-B","nameEN":"OCUMENSION-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧康维视生物-B,01477,欧康维视生物-B股票,欧康维视生物-B股票老虎,欧康维视生物-B股票老虎国际,欧康维视生物-B行情,欧康维视生物-B股票行情,欧康维视生物-B股价,欧康维视生物-B股市,欧康维视生物-B股票价格,欧康维视生物-B股票交易,欧康维视生物-B股票购买,欧康维视生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}